FDA recall record

Pharmakon Pharmaceuticals Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per recall — FDA D-1568-2014

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

Class Iclassification
D-1568-2014official record ID
Sep 3, 2014report date

Recall record at a glance

Official recordD-1568-2014
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmPharmakon Pharmaceuticals
Report dateSep 3, 2014
Recall initiation dateApr 21, 2014
Quantity5 Syringes
LocationNoblesville, IN, United States

Official product description

Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.

Why the product was recalled

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

Distribution information

United States: TX, IL, MD, IN

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.